Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration

Phosducin Regulates Transmission at thePhotoreceptor-to-ON-Bipolar Cell Synapse

(2010) R. Herrmann et al.   JOURNAL OF NEUROSCIENCE

Can novel therapeutics halt the amyloid cascade?

(2010) Niels D Prins et al.   Alzheimers Research & Therapy

Genetic cardiovascular risk factors and age-related macular degeneration

(2009) Paulina Haas et al.   ACTA OPHTHALMOLOGICA

Amyloid-β(1-42) alters structure and function of retinal pigmented epithelial cells

(2009) Julien Bruban et al.   AGING CELL

Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration

(2009) Anand Swaroop et al.   Annual Review of Genomics and Human Genetics

Amyloid-β up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration

(2009) Jiying Wang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited

(2009) Don H. Anderson et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Drusen are associated with local and distant disruptions to human retinal pigment epithelium cells

(2008) Heba Al-Hussaini et al.   EXPERIMENTAL EYE RESEARCH

Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene

(2008) Lars G. Fritsche et al.   HUMAN MUTATION

Age-Related Macular Degeneration

(2008) Rama D. Jager et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting age-related macular degeneration with Alzheimer’s disease based immunotherapies: Anti-amyloid-β antibody attenuates pathologies in an age-related macular degeneration mouse model

(2007) Jin-Dong Ding et al.   VISION RESEARCH